NCT05790213View on ClinicalTrials.gov

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

PHASE2RecruitingINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

December 18, 2028

Study Completion Date

December 18, 2028

Conditions
Prostate Cancer
Interventions
DRUG

Androgen Deprivation Therapy (ADT)

ADT will be given for 3 months. Participants will receive a standard ADT as chosen by their study doctor.

PROCEDURE

Focal prostate ablation (focal therapy)

Focal prostate ablation (focal therapy) is a surgical procedure to destroy cancer cells by destroying a portion of the prostate instead of the whole prostate.

Trial Locations (1)

60637

RECRUITING

UChicago Medicine Comprehensive Cancer Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER